Baltrio Tablets 5/160/10 Milligrams
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
MFDS item code 202006709 · Approved 2020.09.29 · Insurance code 648104560
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression and cardiovascular risk
This medication is used as a combination of amlodipine and valsartan for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy of amlodipine or valsartan. Additionally, rosuvastatin is administered as an adjunct treatment in patients with hypercholesterolemia and dyslipidemia when dietary changes and exercise do not suffice. This medication helps reduce total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis and reducing the risk of cardiovascular disease, stroke, myocardial infarction, and angioplasty. Thus, it is effective for controlling blood pressure and improving cardiovascular disease risk in patients who require management of blood pressure and lipids.
Take 1 tablet once daily with water. If possible, it is recommended that the tablet be taken at the same time each day (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. For patients taking the amlodipine/valsartan combination together with rosuvastatin as separate products, switching to this medicine (a combination product containing the same amount of each active ingredient) may be considered for convenience. ▷ Amlodipine/valsartan combination Before starting the amlodipine/valsartan combination, it is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using either component, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; thus, it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients with allergies to its components or severely impaired liver and kidney function, nor in pregnant or breastfeeding women. Careful monitoring and observation should be conducted in patients with body sodium or fluid depletion, as hypotension may occur. Patients with high potassium levels or those taking potassium-sparing drugs should have their potassium levels monitored frequently. Careful use is required in patients with renal artery stenosis or renal transplant recipients, as it may affect renal function. Special caution is required in patients with heart disease such as heart failure or history of myocardial infarction, and in patients with aortic valve stenosis. This medication may cause muscle-related side effects such as myalgia or muscle weakness; thus, if muscle pain is severe or persistent, consultation with a physician is essential. Dizziness or fatigue may occur during driving or operating machinery, so caution is advised. Interactions with other drugs may occur, so all medications being taken should be disclosed to a physician or pharmacist for consultation. Women who are pregnant or planning to become pregnant should avoid taking this medication, and it should also be avoided during breastfeeding. The safety and efficacy for children under 18 years have not been established, hence it is not recommended for use in this age group. For elderly patients, dosage adjustments are not necessary, but careful monitoring is advised as they may be more sensitive to bodily reactions. Regular liver and kidney function tests should be conducted to monitor for any abnormalities. In cases of overdose, severe hypotension or cardiac problems may occur; therefore, strict adherence to dosage instructions is necessary, and immediate medical attention should be sought in the presence of abnormal symptoms.
Dizziness, sensory abnormalities, chest discomfort, chills, ALT increase, AST increase, weight gain, upper respiratory infection, myalgia, palpitations, ventricular extrasystole, diarrhea, duodenitis, gastritis, dyspnea, eyelid spasms, eyelid edema, hypertriglyceridemia, benign prostatic hyperplasia, nasopharyngitis, influenza, hypersensitivity, visual disturbance, anxiety, headache, drowsiness, orthostatic dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, heart palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, scrotal edema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremor, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, serum sickness, increased serum potassium, vasculitis, elevated liver function levels, angioedema, bullous dermatitis, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, amnesia, peripheral neuropathy, thrombocytopenia, jaundice, increased transaminases, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, ALT increase, chest pain, cough, myalgia, increased CK, dizziness, constipation, AST increase, weakness, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal distension, pruritus, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, chest pain, weight gain, joint pain, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurohyperesthesia, sensory loss, Stevens-Johnson syndrome, pharyngitis, tonsillitis, spinal stenosis, aphasia, nausea, oral bleeding, vomiting, insulin-dependent diabetes mellitus, diabetes complications, leg fracture, spinal fracture, fracture, osteomyelitis, skin mass, palpitations, second-degree atrioventricular block, angina exacerbation, auditory abnormalities, vestibulitis, overactive bladder, increased serum creatinine, retinal detachment, vitreous detachment, unspecified skin tumor-like condition, herpes zoster, herniated disc, laceration
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container as it may be sensitive to air or moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to prolong the medication’s efficacy and safety.
Light pink, oval, biconvex film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.